199 related articles for article (PubMed ID: 28930539)
1. Transcriptional regulation of
Rossi MN; Andresini O; Matteini F; Maione R
Front Biosci (Landmark Ed); 2018 Jan; 23(1):83-108. PubMed ID: 28930539
[TBL] [Abstract][Full Text] [Related]
2. A Beckwith-Wiedemann-Associated
Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
[TBL] [Abstract][Full Text] [Related]
4. p57(Kip2) and cancer: time for a critical appraisal.
Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
[TBL] [Abstract][Full Text] [Related]
6. Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome.
John RM; Ainscough JF; Barton SC; Surani MA
Hum Mol Genet; 2001 Jul; 10(15):1601-9. PubMed ID: 11468278
[TBL] [Abstract][Full Text] [Related]
7. Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome.
Grandjean V; Smith J; Schofield PN; Ferguson-Smith AC
Proc Natl Acad Sci U S A; 2000 May; 97(10):5279-84. PubMed ID: 10779549
[TBL] [Abstract][Full Text] [Related]
8. p57KIP2: "Kip"ing the cell under control.
Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
[TBL] [Abstract][Full Text] [Related]
9. Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Vazquez MP; Gicquel C
Horm Res; 2000; 54(1):1-5. PubMed ID: 11182628
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
12. ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome.
Arima T; Kamikihara T; Hayashida T; Kato K; Inoue T; Shirayoshi Y; Oshimura M; Soejima H; Mukai T; Wake N
Nucleic Acids Res; 2005; 33(8):2650-60. PubMed ID: 15888726
[TBL] [Abstract][Full Text] [Related]
13. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
15. Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2.
Cesario JM; Landin Malt A; Deacon LJ; Sandberg M; Vogt D; Tang Z; Zhao Y; Brown S; Rubenstein JL; Jeong J
Hum Mol Genet; 2015 Sep; 24(17):5024-39. PubMed ID: 26071365
[TBL] [Abstract][Full Text] [Related]
16. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
17. Functional Versatility of the CDK Inhibitor p57
Creff J; Besson A
Front Cell Dev Biol; 2020; 8():584590. PubMed ID: 33117811
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
Mishra S; Lin CL; Huang TH; Bouamar H; Sun LZ
Mol Cancer; 2014 Sep; 13():212. PubMed ID: 25216674
[TBL] [Abstract][Full Text] [Related]
19. The hallmarks of CDKN1C (p57, KIP2) in cancer.
Kavanagh E; Joseph B
Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
[TBL] [Abstract][Full Text] [Related]
20. High Dosage Lithium Treatment Induces DNA Damage and p57
Stampone E; Bencivenga D; Barone C; Aulitto A; Verace F; Della Ragione F; Borriello A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]